CAE (TSE:CAE) Upgraded at Desjardins

Desjardins upgraded shares of CAE (TSE:CAE) (NYSE:CAE) from a hold rating to a buy rating in a report published on Tuesday morning, Marketbeat reports. Desjardins currently has C$40.00 price objective on the stock, up from their previous price objective of C$32.00.

A number of other equities analysts also recently commented on the stock. TD Securities boosted their target price on shares of CAE from C$33.00 to C$34.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. Royal Bank of Canada upped their price objective on CAE from C$27.00 to C$34.00 in a research report on Thursday, November 14th. National Bankshares raised their target price on CAE from C$30.00 to C$34.00 in a research report on Wednesday, November 13th. Cibc World Mkts downgraded CAE from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 4th. Finally, Canaccord Genuity Group raised their price objective on shares of CAE from C$28.00 to C$30.00 in a report on Thursday, November 14th. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, CAE currently has an average rating of “Moderate Buy” and an average target price of C$34.94.

CAE Trading Up 1.2 %

TSE CAE opened at C$35.73 on Tuesday. CAE has a 12 month low of C$22.28 and a 12 month high of C$35.75. The stock has a market capitalization of C$11.39 billion, a P/E ratio of -33.39, a PEG ratio of 1.76 and a beta of 1.91. The firm’s 50-day moving average is C$30.08 and its two-hundred day moving average is C$26.64. The company has a debt-to-equity ratio of 74.24, a current ratio of 0.89 and a quick ratio of 0.71.

About CAE

CAE Inc, together with its subsidiaries, provides simulation training and critical operations support solutions in Canada, the United States, the United Kingdom, Europe, Asia, Oceania and Africa, and Rest of Americas. It operates through three segments: Civil Aviation, Defense and Security, and Healthcare.